FundingWatcher
Home / Investors / Biotech investors / Biotech investors in Shanghai, China

Biotech investors in Shanghai, China

Updated 16 Nov 2026

Reset

Venture funds

6 funds, by portfolio companies funded in the last 12 months
#FundSectorsStages LeadsFunded, 12 months
1 Qiming Venture Partners
Qiming Venture Partners invests in technology, consumer and healthcare companies at early and growth stages, with recent investments including Houmo.AI and AusperBio.
Shanghai, China
Health care, Artificial intelligence Seed, Early stage venture, Late stage venture 50% 11
2 Med-Fine Capital
Med-Fine Capital focuses on healthcare and bio-science, with recent investments including Artivila Therapeutics and Phrontline Biopharma.
Shanghai, China
Health care, Biotech Early stage venture 30% 3
3 BioTrack Capital
BioTrack Capital invests in life sciences, healthcare technology and biotechnology, with recent companies including Yuce Biotechnology and Rigen Biotech.
Shanghai, China
Health care, Biotech Seed, Early stage venture, Late stage venture 33% 2
4 Boyuan Capital
Boyuan Capital operates as an investment platform, with recent companies Yuce Biotechnology and Rigen Biotech.
Shanghai, China
Health care, Biotech Late stage venture 38% 2
5 Linear Capital
Linear Capital invests in data application projects, with recent companies SynMetaBio, Dishi Medical and ReaVis.
Shanghai, China
Artificial intelligence, Hardware Seed, Early stage venture, Late stage venture 31% 2
6 5Y Capital
5Y Capital makes early-stage venture investments, with recent investments in Etern and CellCentric.
Xuhui, China
Artificial intelligence, Commerce Seed, Early stage venture, Late stage venture 31% 2

Table 1. Biotech investors in Shanghai, China: venture capital and micro VC funds ranked by biotech companies whose most recent round closed in the last 12 months. Leads is the share of all recorded investments where the fund was lead investor. Source: FundingWatcher. Data as of 16 November 2026.

Biotech investors in Shanghai, China
One-time CSV
  • 28 firms, 27 with a website
  • 20 firm email addresses
  • 21 phone numbers
  • CRM-ready CSV, 15 columns
  • Download right after payment
With partner contacts
Compiled to order
  • The full list, plus the people who invest
  • Up to 2 partners per firm, compiled to order
  • Name, job title and LinkedIn where found
  • Verified direct email per person
  • List CSV at once, contacts CSV by mail within 24 hours
Download right after paymentFree 10-row sampleSecure checkout by Stripe

Not sure about the data?

Download a free 10-row sample first. No account, no payment.

investors-sector-biotech-shanghai-china.csv28 rows × 15 columns
InvestorTypeLocationEmailPhone
Qiming Venture PartnersVenture capital firmShanghai, China•••@qimingvc.com(+86) •••
Lilly Asia VenturesVenture capital firmShanghai, China•••@lillyasiaventures.com+86 21•••
New Alliance CapitalPrivate equity firmShanghai, China•••@nac-capital.com86-21-•••
Luminous Ventures (former Lightspeed China Partners)Venture capital firmShanghai, China•••@luminousvc.com+86 21•••
Chengwei CapitalVenture capital firmShanghai, China•••@chengwei.com
Hengxu CapitalPrivate equity firmJiading, China•••@hengxucapital.com021-22•••
Pan-Lin CapitalVenture capital firmShanghai, China•••@panlincap.com021-51•••
Viva BioInnovatorVenture capital firmShanghai, China•••@vivabiotech.com

8 rows of the CSV in 5 of its 15 columns, email and phone masked.

28
Investors
20
With email
21
With phone
23
Active in the last 12 months

Source: FundingWatcher. Data as of 16 November 2026. "Last 12 months" is the 365 days to that date.

Biotech investors in Shanghai, China

27 of 28, most investments first
27 rows
# Investor Type Location Invests in Latest portfolio companies Funded, 12 months Investments Lead Exits Email Phone LinkedIn
1 Qiming Venture Partners Venture capital firm Shanghai, China Health care, Artificial intelligence Houmo.AI, Infinigence, AusperBio 21 1,106 555 104 •••@qimingvc.com (+86) ••• In the CSV
2 Lilly Asia Ventures Venture capital firm Shanghai, China Health care, Biotech Precede Biosciences, Akura Medical 2 237 68 49 •••@lillyasiaventures.com +86 21••• In the CSV
3 5Y Capital Venture capital firm Xuhui, China Artificial intelligence, Commerce Etern, CellCentric, BOTINKIT 4 345 108 28 +86 20••• In the CSV
4 BioTrack Capital Venture capital firm Shanghai, China Health care, Biotech Yuce Biotechnology, Shenluo Medical, Rigen Biotech 3 85 28 5 +86-02•••
5 Prox Ventures Venture capital firm Shanghai, China Biotech, Health care Leadinno Medical Valley 1 71 14 1 In the CSV
6 New Alliance Capital Private equity firm, Venture capital firm Shanghai, China Health care, Biotech Degron Therapeutics 1 96 9 10 •••@nac-capital.com 86-21-••• In the CSV
7 Luminous Ventures (former Lightspeed China Partners) Venture capital firm Shanghai, China Hardware, Commerce Enjosim, Yin Gong Technology, Urtopia 8 182 70 13 •••@luminousvc.com +86 21•••
8 Chengwei Capital Venture capital firm Shanghai, China Hardware, Biotech Huizhi International Tourism, Full-Life Technologies 2 113 43 11 •••@chengwei.com In the CSV
9 Linear Capital Venture capital firm Shanghai, China Artificial intelligence, Hardware SynMetaBio, Dishi Medical, ReaVis 3 83 26 1 +61 36••• In the CSV
10 Hengxu Capital Private equity firm Jiading, China Health care, Biotech Kai Medtech, Runxin Micro Technology, Xingsai Bio 3 82 27 6 •••@hengxucapital.com 021-22•••
11 Pan-Lin Capital Venture capital firm Shanghai, China Health care, Biotech Kunteng Tech, AOSSCI, Levinthal 3 74 31 6 •••@panlincap.com 021-51••• In the CSV
12 Viva BioInnovator Venture capital firm Shanghai, China Biotech, Health care Arthrosi Therapeutics, TechnoDerma Medicines, i2o Therapeutics 70 8 5 •••@vivabiotech.com In the CSV
13 Boyuan Capital Venture capital firm Shanghai, China Health care, Biotech Yuce Biotechnology, Rigen Biotech 2 42 16 5 In the CSV
14 Med-Fine Capital Venture capital firm Shanghai, China Health care, Biotech Leadinno Medical Valley, Artivila Therapeutics, Degron Therapeutics 5 77 23 3 •••@medfinecapital.com +86 21••• In the CSV
15 Shanghai Biomedical Industrial Equity Investment Fund Venture capital firm Huangpu, China Health care, Biotech Haimai Medical, AccuPulse, Surgerii Technology 4 60 34 6
16 Grand Flight Investment Private equity firm, Venture capital firm Shanghai, China Biotech, Health care YolTech Therapeutics 1 52 19 8 •••@gfinvestment.com 021-20•••
17 Neovision Capital Venture capital firm Shanghai, China Biotech, Health care Matrixtime Robotics, Xingsai Bio 2 36 9 5 •••@neovisioncap.com +8621 •••
18 Panacea Venture Venture capital firm Shanghai, China Biotech, Health care Myrtelle 1 21 5 1 •••@panaceaventure.com (86-21••• In the CSV
19 DT Capital Partners Private equity firm, Venture capital firm Shanghai, China Fintech, Artificial intelligence Drug Farm 1 154 40 19 •••@dtcap.com +86(21••• In the CSV
20 Fosun International Venture capital firm Shanghai, China Artificial intelligence, Fintech ROBOT++ 1 122 53 24 •••@fosun.com (86 21••• In the CSV
21 Loyal Valley Capital Private equity firm Shanghai, China Health care, Education Surgerii Technology 1 103 48 27 •••@loyalvalleycapital.com +86 (2••• In the CSV
22 Glory Ventures Venture capital firm Shanghai, China Hardware, Artificial intelligence SINOITS, SpacemiT, Silicon Innovation 3 98 28 9 •••@glory-ventures.com 021-61••• In the CSV
23 Dalton Venture Venture capital firm Shanghai, China Health care, Artificial intelligence Astribot 1 67 25 1 •••@daltonventure.cn 021-62•••
24 Marathon Venture Partners Venture capital firm Shanghai, China Fintech, Health care Natus, Yuanyi Biotech, Doctor AI Yisheng Intelligence 60 29 0 •••@marathonvp.com +86108••• In the CSV
25 LongRiver Investments Venture capital firm Xuhui, China Health care, Biotech Rona Therapeutics, Ouro Medicines, Tuge Medical Technology 22 11 2 •••@lr-investments.com +86 21••• In the CSV
26 Jianxin Capital Venture capital firm Shanghai, China Biotech, Health care Huadao Biopharma, Hegea Bio 21 1 5 •••@jianxincapital.com 021-62••• In the CSV
27 Zhongsu Capital Private equity firm, Venture capital firm Shanghai, China Biotech, Health care Jushu Biotech, Silicon Yi Technology 11 6 0

Table 2. Biotech investors in Shanghai, China: the first 27 by recorded investments with a website and a location. Email and phone are masked here and complete in the CSV. Source: FundingWatcher. Data as of 16 November 2026. Base: 28.

Most active in the last 12 months

By portfolio companies funded
#InvestorLocation Funded, 12 monthsPortfolioLatest
1 Qiming Venture Partners Shanghai, China 21 154 Houmo.AI, Infinigence, AusperBio
2 Luminous Ventures (former Lightspeed China Partners) Shanghai, China 8 48 Enjosim, Yin Gong Technology, Urtopia
3 Med-Fine Capital Shanghai, China 5 8 Leadinno Medical Valley, Artivila Therapeutics, Degron Therapeutics
4 5Y Capital Xuhui, China 4 57 Etern, CellCentric, BOTINKIT
5 Shanghai Biomedical Industrial Equity Investment Fund Huangpu, China 4 11 Haimai Medical, AccuPulse, Surgerii Technology
6 Pan-Lin Capital Shanghai, China 3 14 Kunteng Tech, AOSSCI, Levinthal
7 BioTrack Capital Shanghai, China 3 9 Yuce Biotechnology, Shenluo Medical, Rigen Biotech
8 Hengxu Capital Jiading, China 3 11 Kai Medtech, Runxin Micro Technology, Xingsai Bio
9 Linear Capital Shanghai, China 3 20 SynMetaBio, Dishi Medical, ReaVis
10 Glory Ventures Shanghai, China 3 23 SINOITS, SpacemiT, Silicon Innovation
11 Neovision Capital Shanghai, China 2 6 Matrixtime Robotics, Xingsai Bio
12 Boyuan Capital Shanghai, China 2 6 Yuce Biotechnology, Rigen Biotech
13 Chengwei Capital Shanghai, China 2 31 Huizhi International Tourism, Full-Life Technologies
14 Lilly Asia Ventures Shanghai, China 2 14 Precede Biosciences, Akura Medical
15 Dalton Venture Shanghai, China 1 9 Astribot

Table 3. Biotech investors in Shanghai, China: investors in the most companies whose most recent round falls in the last 12 months. Source: FundingWatcher. Data as of 16 November 2026.

Latest rounds in their portfolios

Newest first
10 rows
Company What they do Sector Location Last round Amount Date Total raised Investors on this list Employees Founded
Enjosim Enjosim researches, manufactures, and sells self-delivery systems for biomacromolecule pharmaceuticals. Biotech Shanghai, China Series B $30.1M 2026-11-02 $30.1M Luminous Ventures (former Lightspeed China Partners) 51 to 100 2021
Astribot Astribot develops intelligent robotic systems that assist people in everyday and professional settings. Artificial intelligence Shenzhen, China Series B $149.4M 2026-10-13 $297.2M Dalton Venture 101 to 250 2022
Infinigence Infinigence develops AI infrastructure and computing solutions for training and deploying AI models. Artificial intelligence Xuhui, China Series C $343.7M 2026-10-12 $587.5M Qiming Venture Partners 51 to 100 2023
Yuce Biotechnology Yuce Biotechnology focuses on the industrialization of single-molecule immunodiagnostic technologies. Biotech Suzhou, China Series B $7.4M 2026-08-31 $22.4M BioTrack Capital, Boyuan Capital 101 to 250 2019
AusperBio AusperBio develops oligonucleotide therapeutics and targeted delivery technologies for treating diseases. Biotech Hangzhou, China Series C $120.0M 2026-08-27 $357.0M Qiming Venture Partners, Hankang Capital 51 to 100 2019
Leadinno Medical Valley Leadinno Medical Valley produces medical devices that regulate neurological functions. Health care Beijing, China Series B $29.7M 2026-08-17 $90.3M Prox Ventures, Med-Fine Capital 10,001 or more 2016
Kai Medtech Kai Medtech markets and sells vascular intervention medical devices. Health care Minhang, China Series D $73.9M 2026-07-28 $105.3M Hengxu Capital 51 to 100 2019
Drug Farm Drug Farm develops therapies for infectious, immunological, and inflammatory diseases using genetics and artificial intelligence. Artificial intelligence Shanghai, China Series D $55.0M 2026-07-13 $138.0M DT Capital Partners 101 to 250 2015
Tianhu Technology Tianhu Technology uses computational chemistry and artificial intelligence to design new drug molecules. Artificial intelligence Minhang, China Series A $29.0M 2026-07-13 $54.2M Qiming Venture Partners 11 to 50 2021
SynMetaBio SynMetaBio develops synthetic biological materials by combining synthetic biology with material design. Biotech Shanghai, China Series A $14.7M 2026-07-06 $16.1M Linear Capital 11 to 50 2021

Table 4. Biotech investors in Shanghai, China: the 10 most recent rounds of companies they back. Source: FundingWatcher. Data as of 16 November 2026.

Portfolio sectors

Portfolio sectorsCompaniesShare
Software 302 59%
Health care 147 29%
Biotech 106 21%
Hardware 103 20%
Artificial intelligence 101 20%
Fintech 47 9%
Commerce 39 8%
Education 23 5%
Energy 12 2%
Cybersecurity 10 2%

Table 5. Biotech investors in Shanghai, China: portfolio companies by sector. Source: FundingWatcher. Data as of 16 November 2026.

Investment stages

Investment stagesInvestorsShare
Early stage investors 25 89%
Late stage investors 21 75%
Seed investors 18 64%
Venture investors 15 54%
Private equity investors 7 25%
Post IPO investors 4 14%

Table 6. Biotech investors in Shanghai, China by stage they invest at. Source: FundingWatcher. Data as of 16 November 2026.

Cities

CitiesInvestorsShare
Shanghai 24 86%
Xuhui 2 7%
Jiading 1 4%
Huangpu 1 4%

Table 7. Biotech investors in Shanghai, China by headquarters city. Source: FundingWatcher. Data as of 16 November 2026.

Founded

FoundedInvestorsShare
2020s 3 11%
2010s 16 59%
2000s 6 22%
1990s 2 7%

Table 8. Biotech investors in Shanghai, China by founding decade. Source: FundingWatcher. Data as of 16 November 2026.

Method

Sources, fields and exclusions of both files: Method.

Questions

How many biotech investors in Shanghai, China are on the list?
28, in the file dated 16 November 2026. 23 of them invested in a company whose most recent round falls in the last 12 months.
How many have an email address?
20 of the 28 carry an email address in the download and 21 a phone number.
What does the CSV contain?
One row per investor, 15 columns: name, types, stages, city, region, country, founded, website, linkedin, investments, funded_last_12m, exits, lead_investments, email, phone.
How much does the list cost?
$29 one-time for all 28 rows, no account. Every investor and every startup, two files, cost $99. With partner contacts, up to 2 per firm compiled to order and mailed within 24 hours, $199.
What arrives after payment?
At once: the CSV with 28 rows, 20 firm email addresses and 21 phone numbers, on the page after payment and by mail. The emails are the address a firm publishes: 14 of the 20 are inboxes such as info@ or contact@. No partner names.
Can I see rows before buying?
The 3 rows under the buy button are rows of the CSV with every column. The form below it mails 10 rows.
How current is the data?
The file is dated 16 November 2026. The download link serves the current file each time it is opened.

Biotech investors in Shanghai, China: 28 rows, CSV, $29 one-time.

At once: the CSV with 28 rows, 20 firm email addresses and 21 phone numbers, on the page after payment and by mail.

The emails are the address a firm publishes: 14 of the 20 are inboxes such as info@ or contact@. No partner names.

Columns: name, types, stages, city, region, country, founded, website, linkedin, investments, funded_last_12m, exits, lead_investments, email, phone.

With partner contacts: $199 one-time. List CSV right after payment; up to 2 verified partner emails per firm compiled to order within 24 hours.

Not sure about the data?

Download a free 10-row sample first. No account, no payment.

Investor types in Shanghai

Other portfolio sectors in Shanghai

Biotech investors elsewhere

Biotech startups

Cite: FundingWatcher, 28 biotech investors in Shanghai, China, 16 November 2026. https://fundingwatcher.com/investors/sector/biotech/shanghai-china/